Ryan Specialty (RYAN) Stock Forecast, Price Target & Predictions
RYAN Stock Forecast
Ryan Specialty stock forecast is as follows: an average price target of $57.00 (represents a -10.36% downside from RYAN’s last price of $63.59) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
RYAN Price Target
The average price target for Ryan Specialty (RYAN) is $57.00 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $76.00 to $42.00. This represents a potential -10.36% downside from RYAN's last price of $63.59.
RYAN Analyst Ratings
According to 7 Wall Street analysts, Ryan Specialty's rating consensus is 'Buy'. The analyst rating breakdown for RYAN stock is 0 'Strong Buy' (0.00%), 5 'Buy' (71.43%), 2 'Hold' (28.57%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Ryan Specialty Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 04, 2024 | Alex Scott | Barclays | $76.00 | $64.03 | 18.69% | 19.52% |
| Jul 09, 2024 | Brian Meredith | UBS | $67.00 | $57.10 | 17.34% | 5.36% |
| May 03, 2024 | Mark Dwelle | RBC Capital | $55.00 | $52.95 | 3.87% | -13.51% |
| Dec 16, 2022 | - | Wells Fargo | $45.00 | $40.69 | 10.59% | -29.23% |
| Dec 15, 2022 | - | Citigroup | $42.00 | $41.10 | 2.19% | -33.95% |
| Nov 11, 2022 | - | RBC Capital | $46.00 | $37.62 | 22.28% | -27.66% |
| Nov 11, 2022 | - | Wells Fargo | $41.00 | $44.45 | -7.76% | -35.52% |
The latest Ryan Specialty stock forecast, released on Sep 04, 2024 by Alex Scott from Barclays, set a price target of $76.00, which represents a 18.69% increase from the stock price at the time of the forecast ($64.03), and a 19.52% increase from RYAN last price ($63.59).
Ryan Specialty Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 2 | 3 |
| Avg Price Target | $76.00 | $71.50 | $66.00 |
| Last Closing Price | $63.59 | $63.59 | $63.59 |
| Upside/Downside | 19.52% | 12.44% | 3.79% |
In the current month, the average price target of Ryan Specialty stock is $76.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 19.52% increase as opposed to Ryan Specialty's last price of $63.59. This month's average price target is up 6.29% compared to last quarter, and up 15.15% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 04, 2024 | Barclays | - | Overweight | Initialise |
| Jul 23, 2024 | Citigroup | Buy | Buy | Hold |
| Jul 11, 2024 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| Jul 09, 2024 | UBS | Buy | Buy | Hold |
| May 22, 2024 | Bank of America Securities | - | Buy | Initialise |
| May 06, 2024 | Wolfe Research | - | Peer Perform | Downgrade |
| May 03, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
| Dec 16, 2022 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| Dec 15, 2022 | Citigroup | - | Neutral | Initialise |
| Nov 11, 2022 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Ryan Specialty's last stock rating was published by Barclays on Sep 04, 2024. The company Initialise its RYAN rating from "null" to "Overweight".
Ryan Specialty Financial Forecast
Ryan Specialty Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $532.86M | $501.94M | $585.15M | $457.60M | $435.01M | $412.00M | $491.29M | $386.89M | $378.54M | $352.77M | $390.01M |
| Avg Forecast | $860.86M | $816.18M | $948.07M | $765.42M | $749.85M | $718.09M | $824.50M | $664.16M | $649.16M | $601.44M | $695.56M | $549.06M | $524.08M | $496.35M | $575.80M | $437.54M | $425.48M | $421.02M | $459.81M | $370.47M | $379.88M | $324.30M | $387.21M |
| High Forecast | $914.77M | $867.28M | $1.01B | $813.35M | $796.80M | $763.05M | $876.13M | $705.75M | $689.80M | $639.10M | $739.11M | $583.44M | $528.15M | $527.43M | $611.85M | $464.94M | $452.13M | $447.38M | $474.27M | $382.12M | $391.82M | $334.50M | $399.39M |
| Low Forecast | $833.10M | $789.86M | $917.49M | $740.74M | $725.67M | $694.93M | $797.91M | $642.74M | $628.22M | $601.43M | $673.13M | $531.35M | $520.02M | $480.34M | $557.23M | $423.43M | $411.76M | $407.44M | $452.33M | $364.44M | $373.70M | $319.02M | $380.92M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.01% | 1.02% | 1.05% | 1.02% | 0.98% | 1.07% | 1.04% | 1.00% | 1.09% | 1.01% |
Ryan Specialty's average Quarter revenue forecast for Mar 24 based on 4 analysts is $549.06M, with a low forecast of $531.35M, and a high forecast of $583.44M. RYAN's average Quarter revenue forecast represents a 3.04% increase compared to the company's last Quarter revenue of $532.86M (Dec 23).
Ryan Specialty EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $149.00M | $69.82M | $122.84M | $70.09M | $79.95M | $71.15M | $87.98M | $52.03M | $61.90M | $42.65M | $113.27M |
| Avg Forecast | $151.94M | $144.06M | $167.34M | $135.10M | $132.35M | $126.74M | $145.53M | $117.23M | $114.58M | $106.15M | $122.77M | $96.91M | $92.50M | $87.61M | $101.63M | $77.23M | $75.10M | $34.91M | $77.92M | $65.39M | $67.05M | $27.60M | $68.34M |
| High Forecast | $161.46M | $153.08M | $177.81M | $143.56M | $140.64M | $134.68M | $154.64M | $124.57M | $121.75M | $112.80M | $130.45M | $102.98M | $93.22M | $93.09M | $107.99M | $82.06M | $79.80M | $41.89M | $93.51M | $67.44M | $69.16M | $33.12M | $70.49M |
| Low Forecast | $147.04M | $139.41M | $161.94M | $130.74M | $128.08M | $122.66M | $140.83M | $113.44M | $110.88M | $106.15M | $118.81M | $93.78M | $91.78M | $84.78M | $98.35M | $74.74M | $72.68M | $27.93M | $62.34M | $64.32M | $65.96M | $22.08M | $67.23M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.61% | 0.80% | 1.21% | 0.91% | 1.06% | 2.04% | 1.13% | 0.80% | 0.92% | 1.55% | 1.66% |
4 analysts predict RYAN's average Quarter EBITDA for Mar 24 to be $96.91M, with a high of $102.98M and a low of $93.78M. This is -34.96% lower than Ryan Specialty's previous annual EBITDA (Dec 23) of $149.00M.
Ryan Specialty Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $58.50M | $15.70M | $83.82M | $36.46M | $45.78M | $29.28M | $70.12M | $18.08M | $29.62M | $-32.59M | $63.41M |
| Avg Forecast | $188.70M | $172.53M | $233.27M | $144.38M | $154.06M | $142.35M | $188.88M | $121.72M | $124.69M | $112.73M | $152.70M | $94.80M | $93.30M | $83.93M | $120.35M | $66.78M | $70.79M | $-1.09M | $21.70M | $60.00M | $76.71M | $-863.18K | $86.51M |
| High Forecast | $204.06M | $186.58M | $252.26M | $156.13M | $166.60M | $153.93M | $204.26M | $131.63M | $134.84M | $118.23M | $165.13M | $102.52M | $95.96M | $90.77M | $130.15M | $72.21M | $76.55M | $-873.53K | $26.04M | $62.46M | $79.84M | $-690.54K | $90.04M |
| Low Forecast | $180.79M | $165.30M | $223.49M | $138.32M | $147.61M | $136.38M | $180.96M | $116.62M | $119.46M | $109.98M | $146.30M | $90.83M | $90.63M | $80.42M | $115.31M | $63.98M | $67.82M | $-1.31M | $17.36M | $58.74M | $75.08M | $-1.04M | $84.68M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.63% | 0.19% | 0.70% | 0.55% | 0.65% | -26.81% | 3.23% | 0.30% | 0.39% | 37.76% | 0.73% |
Ryan Specialty's average Quarter net income forecast for Mar 24 is $94.80M, with a range of $90.83M to $102.52M. RYAN's average Quarter net income forecast represents a 62.05% increase compared to the company's last Quarter net income of $58.50M (Dec 23).
Ryan Specialty SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $69.29M | $81.61M | $359.42M | $327.66M | $323.10M | $358.55M | $316.63M | $295.76M | $325.29M | $267.49M |
| Avg Forecast | $671.13M | $636.29M | $739.11M | $596.72M | $584.58M | $559.82M | $642.78M | $517.78M | $506.08M | $468.88M | $542.26M | $428.04M | $408.57M | $386.96M | $448.89M | $341.11M | $331.71M | $266.26M | $42.95M | $288.82M | $296.15M | $210.48M | $301.87M |
| High Forecast | $713.15M | $676.13M | $785.40M | $634.09M | $621.19M | $594.88M | $683.03M | $550.20M | $537.77M | $498.24M | $576.21M | $454.85M | $411.74M | $411.19M | $477.00M | $362.47M | $352.48M | $319.51M | $51.54M | $297.90M | $305.46M | $252.58M | $311.36M |
| Low Forecast | $649.49M | $615.77M | $715.28M | $577.48M | $565.73M | $541.77M | $622.05M | $501.08M | $489.76M | $468.88M | $524.77M | $414.24M | $405.41M | $374.48M | $434.42M | $330.11M | $321.01M | $213.01M | $34.36M | $284.12M | $291.33M | $168.39M | $296.96M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.18% | 0.18% | 1.05% | 0.99% | 1.21% | 8.35% | 1.10% | 1.00% | 1.55% | 0.89% |
Ryan Specialty's average Quarter SG&A projection for Dec 23 is $408.57M, based on 5 Wall Street analysts, with a range of $405.41M to $411.74M. The forecast indicates a 489.68% rise compared to RYAN last annual SG&A of $69.29M (Sep 23).
Ryan Specialty EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.21 | $0.14 | $0.74 | $0.12 | $0.16 | $0.27 | $0.23 | $0.17 | $0.27 | $-0.30 | $0.60 |
| Avg Forecast | $0.70 | $0.64 | $0.86 | $0.53 | $0.57 | $0.52 | $0.70 | $0.45 | $0.46 | $0.42 | $0.56 | $0.35 | $0.34 | $0.31 | $0.44 | $0.25 | $0.26 | $0.26 | $0.35 | $0.22 | $0.28 | $0.18 | $0.32 |
| High Forecast | $0.75 | $0.69 | $0.93 | $0.58 | $0.61 | $0.57 | $0.75 | $0.49 | $0.50 | $0.44 | $0.61 | $0.38 | $0.35 | $0.33 | $0.48 | $0.27 | $0.28 | $0.28 | $0.37 | $0.23 | $0.29 | $0.19 | $0.33 |
| Low Forecast | $0.67 | $0.61 | $0.82 | $0.51 | $0.54 | $0.50 | $0.67 | $0.43 | $0.44 | $0.41 | $0.54 | $0.33 | $0.33 | $0.30 | $0.43 | $0.24 | $0.25 | $0.25 | $0.35 | $0.22 | $0.28 | $0.18 | $0.31 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.61% | 0.45% | 1.67% | 0.49% | 0.61% | 1.05% | 0.65% | 0.77% | 0.95% | -1.66% | 1.88% |
According to 4 Wall Street analysts, Ryan Specialty's projected average Quarter EPS for Mar 24 is $0.35, with a low estimate of $0.33 and a high estimate of $0.38. This represents a 66.45% increase compared to RYAN previous annual EPS of $0.21 (Dec 23).
Ryan Specialty Peer Comparison by Price Target
RYAN Forecast FAQ
Is Ryan Specialty a good buy?
Yes, according to 7 Wall Street analysts, Ryan Specialty (RYAN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 71.43% of RYAN's total ratings.
What is RYAN's price target?
Ryan Specialty (RYAN) average price target is $57 with a range of $42 to $76, implying a -10.36% from its last price of $63.59. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Ryan Specialty stock go up soon?
According to Wall Street analysts' prediction for RYAN stock, the company can go down by -10.36% (from the last price of $63.59 to the average price target of $57), up by 19.52% based on the highest stock price target, and down by -33.95% based on the lowest stock price target.
Can Ryan Specialty stock reach $100?
RYAN's average twelve months analyst stock price target of $57 does not support the claim that Ryan Specialty can reach $100 in the near future.
What is Ryan Specialty's current price target trend?
1 Wall Street analyst forecast a $76 price target for Ryan Specialty (RYAN) this month, up 19.52% from its last price of $63.59. Compared to the last 3 and 12 months, the average price target increased by 12.44% and increased by 3.79%, respectively.
What are Ryan Specialty's analysts' financial forecasts?
Ryan Specialty's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.96B (high $3.14B, low $2.86B), average EBITDA is $521.84M (high $554.52M, low $505.01M), average net income is $607.01M (high $656.42M, low $581.56M), average SG&A $2.3B (high $2.45B, low $2.23B), and average EPS is $2.24 (high $2.42, low $2.14). RYAN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $3.39B (high $3.6B, low $3.28B), average EBITDA is $598.43M (high $635.91M, low $579.13M), average net income is $738.88M (high $799.03M, low $707.9M), average SG&A $2.64B (high $2.81B, low $2.56B), and average EPS is $2.72 (high $2.95, low $2.61).
Did the RYAN's actual financial results beat the analysts' financial forecasts?
Based on Ryan Specialty's last annual report (Dec 2023), the company's revenue was $2.08B, beating the average analysts forecast of $2.03B by 2.15%. Apple's EBITDA was $359.08M, beating the average prediction of $358.96M by 0.03%. The company's net income was $194.48M, missing the average estimation of $364.36M by -46.62%. Apple's SG&A was $276.18M, missing the average forecast of $1.59B by -82.58%. Lastly, the company's EPS was $1.55, beating the average prediction of $1.34 by 15.38%. In terms of the last quarterly report (Dec 2023), Ryan Specialty's revenue was $532.86M, beating the average analysts' forecast of $524.08M by 1.68%. The company's EBITDA was $149M, beating the average prediction of $92.5M by 61.08%. Ryan Specialty's net income was $58.5M, missing the average estimation of $93.3M by -37.29%. The company's SG&A was $0, missing the average forecast of $408.57M by -100.00%. Lastly, the company's EPS was $0.21, missing the average prediction of $0.344 by -38.95%